MD FACC - GRPH Old CEO Pres
| GRPHDelisted Stock | USD 2.67 0.05 1.84% |
Insider
MD FACC is CEO Pres of GRPH Old
| Age | 50 |
| Phone | 650 484 0886 |
| Web | https://graphitebio.com |
GRPH Old Management Efficiency
The company has return on total asset (ROA) of (0.1799) % which means that it has lost $0.1799 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5195) %, meaning that it created substantial loss on money invested by shareholders. GRPH Old's management efficiency ratios could be used to measure how well GRPH Old manages its routine affairs as well as how well it operates its assets and liabilities.GRPH Old currently holds 362 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. GRPH Old has a current ratio of 26.53, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about GRPH Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Christopher Ogden | CytomX Therapeutics | 41 | |
| David Hanley | Nuvation Bio | 55 | |
| Iraj Ali | Achilles Therapeutics PLC | 50 | |
| Michele Anderson | Assembly Biosciences | N/A | |
| W Vernon | Nuvation Bio | 65 | |
| Robert MD | Sensei Biotherapeutics | 58 | |
| Thomas Templeman | Nuvation Bio | 60 | |
| Daniel Welch | Nuvation Bio | 63 | |
| Timothy Moore | Instil Bio | 63 | |
| Sandeep MD | Instil Bio | 56 | |
| Uri MD | Assembly Biosciences | 53 | |
| Tharaknath Rao | Assembly Biosciences | N/A | |
| Stacy Markel | Nuvation Bio | 60 | |
| Jamie Moore | CytomX Therapeutics | N/A | |
| Robert Coutts | Achilles Therapeutics PLC | 41 | |
| DPHIL DPhil | CytomX Therapeutics | 57 | |
| Sumita JD | Instil Bio | 50 | |
| Kim Blickenstaff | Nuvation Bio | 68 | |
| Erin Colgan | Sensei Biotherapeutics | 43 | |
| Sergey Yurasov | Nuvation Bio | 51 | |
| Hoyoung MD | CytomX Therapeutics | 56 | |
Management Performance
| Return On Equity | -0.52 | |||
| Return On Asset | -0.18 |
GRPH Old Leadership Team
Elected by the shareholders, the GRPH Old's board of directors comprises two types of representatives: GRPH Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GRPH. The board's role is to monitor GRPH Old's management team and ensure that shareholders' interests are well served. GRPH Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GRPH Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephanie Yao, Vice Relations | ||
| Maria MD, Academic Board | ||
| Christine PMP, Chief Operations | ||
| Jerry Cacia, Chief Officer | ||
| Philip Gutry, Chief Officer | ||
| Jane Grogan, Chief Officer | ||
| MD FACC, CEO Pres | ||
| Daniel Dever, CoFounder Research | ||
| Alethia Young, Chief Officer | ||
| Kimberlee CPA, CEO and Presidentident | ||
| Matthew MD, Academic Director |
GRPH Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GRPH Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.52 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | 1.88 M | |||
| Shares Outstanding | 58.24 M | |||
| Shares Owned By Insiders | 9.17 % | |||
| Shares Owned By Institutions | 84.40 % | |||
| Number Of Shares Shorted | 704.04 K | |||
| Price To Earning | 0.70 X | |||
| Price To Book | 1.01 X | |||
| EBITDA | (70.7 M) |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in GRPH Stock
If you are still planning to invest in GRPH Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GRPH Old's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |